Finance

Beta
Lists
CNTA:NASDAQ
Centessa Pharmaceuticals PLC - ADR
$39.62
-0.45%
(-0.18) 1D
$39.62
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNTA...
Open
$39.76
High
$39.81
Low
$39.62
Mkt. cap
6.13B
Avg. vol.
1.26M
Volume
1.70M
52-wk high
$40.25
52-wk low
$11.55
EPS
-$1.77
Beta
1.11
Shares outstanding
154.73M
No. of employees
129
Open
$39.76
High
$39.81
Low
$39.62
Mkt. cap
6.13B
Avg. vol.
1.26M
Volume
1.70M
52-wk high
$40.25
52-wk low
$11.55
EPS
-$1.77
Beta
1.11
Shares outstanding
154.73M
No. of employees
129
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to CNTA in the past 3 months
Hold
Buy
1
Hold
9
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for CNTA in the last 3 months.
Highest
Current $39.62
$47.00 (+18.63%)
Average
$42.40 (+7.02%)
Lowest
$38.00 (-4.09%)
News stories
From sources across the web
About Centessa Pharmaceuticals PLC - ADR
CEO-
Employees129
Founded2020
Headquarters-
SectorBiotechnology
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.52 / -$0.41
-28.08%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
42.74M
41.56M
54.48M
59.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.91M
12.23M
14.00M
19.88M
Operating expense
54.65M
53.79M
68.47M
79.77M
Total operating expenses
54.65M
53.79M
68.47M
79.77M
Operating income
-54.65M
-53.79M
-68.47M
-79.77M
Other non operating income
-
-10.00K
3.00K
-25.00K
EBT including unusual items
-49.56M
-54.72M
-66.68M
-78.39M
EBT excluding unusual items
-49.56M
-54.72M
-66.68M
-78.39M
Income tax expense
778.00K
166.00K
-522.00K
850.00K
Effective tax rate
-1.57%
-0.30%
0.78%
-1.08%
Other operating expenses
-
-
-
-
Net income
-50.34M
-54.89M
-66.16M
-79.24M
Net profit margin
-
-
-
-
Earnings per share
-0.38
-0.41
-0.48
-0.52
Interest and investment income
4.38M
3.76M
4.49M
5.14M
Interest expense
-2.88M
-2.89M
-2.81M
-2.73M
Net interest expenses
1.50M
875.00K
1.68M
2.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
-54.43M
-53.55M
-68.39M
-79.53M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more